Applicant, as named in the Orange Book

Reckitt Benckiser

Next listed expiry: Mucinex 12hr Cold & Fever Multi-Symptom on 11 Oct 2036. 1 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Mucinex 12hr Cold & Fever Multi-Symptom NDA 217338 dextromethorphan hydrobromide; guaifenesin; naproxen sodium	dextromethorphan hydrobromide; guaifenesin; naproxen sodium	11 Oct 2036 patent	patent

Recent events

Delsym · Generic approved · ANDA 218417, Aurobindo Pharma LtdApproved 15 Apr 2026Detected 25 Oct 2026

Products without listed protection (4)

Drug	Ingredient	Earliest generic entry	Basis
Delsym NDA 018658 dextromethorphan polistirex	dextromethorphan polistirex	open now no listed protection	no listed protection
Mucinex NDA 021282 · 2 strengths guaifenesin	guaifenesin	open now no listed protection	no listed protection
Mucinex D NDA 021585 · 2 strengths guaifenesin; pseudoephedrine hydrochloride	guaifenesin; pseudoephedrine hydrochloride	open now no listed protection	no listed protection
Mucinex Dm NDA 021620 · 2 strengths dextromethorphan hydrobromide; guaifenesin	dextromethorphan hydrobromide; guaifenesin	open now no listed protection	no listed protection